Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevnar 13 in Children with Sickle Cell Disease Previously Immunized with 23vPS
NCT00918580Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2009
- Primary completion
- Mar 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 7
01
Overview
A Phase 3 trial of Prevnar 13 in pneumococcal disease, sponsored by Pfizer. Started Nov 2009; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT00918580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918580.